The Hemophilia Joint Health Score version 2.1 Validation in Adult Patients Study: A multicenter international study.

adult arthropathy hemarthrosis hemophilia validity of results

Journal

Research and practice in thrombosis and haemostasis
ISSN: 2475-0379
Titre abrégé: Res Pract Thromb Haemost
Pays: United States
ID NLM: 101703775

Informations de publication

Date de publication:
Feb 2022
Historique:
received: 11 11 2021
revised: 02 02 2022
accepted: 08 02 2022
entrez: 31 3 2022
pubmed: 1 4 2022
medline: 1 4 2022
Statut: epublish

Résumé

The Hemophilia Joint Health Score (HJHS) was developed and validated to detect arthropathy in children. Additional evidence is required to show validity in adults. We studied the convergent and discriminant construct validity of the HJHS version 2.1(HJHSv2.1) in adults with hemophilia. A secondary aim was to define age-related normative adult HJHSv2.1 reference values. We studied 192 adults with hemophilia, and 120 healthy adults in four age-matched groups-18 to 29, 30 to 40, 41 to 50, and >50 years-at nine centers. Trained physiotherapists scored the HJHS and World Federation of Hemophilia (WFH) joint score. Health history, the Functional Independence Scale of Hemophilia (FISH), Hemophilia Activities List (HAL), and Short-Form McGill Pain Questionnaire (SF-MPQ) were also collected. The median age was 35.0 years. Of participants with hemophilia, 68% had severe, 14% moderate, and 18% mild disease. The HJHS correlated strongly with WFH score (Spearman's rho [ The HJHS shows evidence of strong convergent and discriminant construct validity to detect arthropathy in adults with hemophilia and is well suited for use in this population.

Sections du résumé

Background UNASSIGNED
The Hemophilia Joint Health Score (HJHS) was developed and validated to detect arthropathy in children. Additional evidence is required to show validity in adults. We studied the convergent and discriminant construct validity of the HJHS version 2.1(HJHSv2.1) in adults with hemophilia. A secondary aim was to define age-related normative adult HJHSv2.1 reference values.
Methods UNASSIGNED
We studied 192 adults with hemophilia, and 120 healthy adults in four age-matched groups-18 to 29, 30 to 40, 41 to 50, and >50 years-at nine centers. Trained physiotherapists scored the HJHS and World Federation of Hemophilia (WFH) joint score. Health history, the Functional Independence Scale of Hemophilia (FISH), Hemophilia Activities List (HAL), and Short-Form McGill Pain Questionnaire (SF-MPQ) were also collected.
Results UNASSIGNED
The median age was 35.0 years. Of participants with hemophilia, 68% had severe, 14% moderate, and 18% mild disease. The HJHS correlated strongly with WFH score (Spearman's rho [
Conclusions UNASSIGNED
The HJHS shows evidence of strong convergent and discriminant construct validity to detect arthropathy in adults with hemophilia and is well suited for use in this population.

Identifiants

pubmed: 35356667
doi: 10.1002/rth2.12690
pii: S2475-0379(22)01178-5
pmc: PMC8956786
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e12690

Commentaires et corrections

Type : ErratumIn
Type : ErratumIn

Informations de copyright

© 2022 The Authors. Research and Practice in Thrombosis and Haemostasis published by Wiley Periodicals LLC on behalf of International Society on Thrombosis and Haemostasis (ISTH).

Références

Haemophilia. 2020 Aug;26 Suppl 6:1-158
pubmed: 32744769
Am J Hematol. 2020 Aug;95(8):960-965
pubmed: 32356313
Semin Hematol. 1993 Jul;30(3 Suppl 2):3-6
pubmed: 8367740
Haemophilia. 2017 Nov;23(6):934-940
pubmed: 28873289
Haemophilia. 2019 Jan;25(1):e1-e10
pubmed: 30427100
Res Pract Thromb Haemost. 2019 May 20;3(3):405-411
pubmed: 31294328
Semin Hematol. 2006 Jan;43(1 Suppl 1):S27-32
pubmed: 16427381
J Thromb Haemost. 2014 Nov;12(11):1935-9
pubmed: 25059285
Haemophilia. 2006 Jan;12(1):36-46
pubmed: 16409173
Haemophilia. 2017 Sep;23(5):e403-e408
pubmed: 28758324
Haemophilia. 2013 Nov;19(6):944-50
pubmed: 23730725
Blood. 2015 Mar 26;125(13):2038-44
pubmed: 25712992
Haemophilia. 2020 Nov;26(6):1072-1080
pubmed: 33058441
Haemophilia. 2017 Jan;23(1):11-24
pubmed: 27633342
Haemophilia. 2006 Sep;12(5):518-25
pubmed: 16919083
J Thromb Haemost. 2010 Sep;8(9):1895-902
pubmed: 20586922
Arthritis Care Res (Hoboken). 2011 Feb;63(2):223-30
pubmed: 20862683
Pain. 1987 Aug;30(2):191-197
pubmed: 3670870
Patient Prefer Adherence. 2017 Aug 09;11:1369-1380
pubmed: 28860720
Thromb Haemost. 2017 Aug 1;117(8):1465-1470
pubmed: 28492695
Haemophilia. 2011 Nov;17(6):926-30
pubmed: 21435115
Haemophilia. 2005 Nov;11(6):598-602
pubmed: 16236109
Haemophilia. 2007 Sep;13(5):620-6
pubmed: 17880453
Blood. 2009 Jul 23;114(4):779-84
pubmed: 19357395
Haemophilia. 2004 Sep;10(5):565-71
pubmed: 15357785
Haemophilia. 2018 Nov;24(6):988-994
pubmed: 30295404
HSS J. 2010 Feb;6(1):37-42
pubmed: 19921342

Auteurs

Jean St-Louis (J)

Department of Hematology CHU Sainte-Justine and Hôpital Maisonneuve-Rosemont Montréal Québec Canada.
Department of Medicine Université de Montréal Montréal Québec Canada.

Audrey Abad (A)

Child Health Evaluative Sciences, Research Institute The Hospital for Sick Children Toronto Ontario Canada.

Sharon Funk (S)

Hemophilia and Thrombosis Center University of Colorado Denver Colorado USA.

Merlyn Tilak (M)

Department of Physical Medicine & Rehabilitation Christian Medical College Vellore India.

Stephen Classey (S)

Haemostasis and Thrombosis Centre St Thomas' Hospital London UK.

Nichan Zourikian (N)

Pediatric/Adult Comprehensive Hemostasis Center CHU Sainte-Justine Montréal Québec Canada.

Paul McLaughlin (P)

Katharine Dormandy Haemophilia and Thrombosis Centre The Royal Free Hospital London UK.

Sébastien Lobet (S)

Haemostasis and Thrombosis Unit Division of Haematology Cliniques Universitaires Saint-Luc Brussels Belgium.

Grace Hernandez (G)

The Center for Inherited Blood Disorders (CIBD) Orange County California USA.

Stacie Akins (S)

Indiana Hemophilia & Thrombosis Center Indianapolis Indiana USA.

Anna J Wells (AJ)

Haemophilia, Haemostasis & Thrombosis Centre Hampshire Hospitals NHS Foundation Trust Basingstoke UK.

Marilyn Manco-Johnson (M)

Hemophilia and Thrombosis Center University of Colorado Denver Colorado USA.

Judy John (J)

Department of Physical Medicine & Rehabilitation Christian Medical College Vellore India.

Steve Austin (S)

Haemostasis and Thrombosis Centre St Thomas' Hospital London UK.

Pratima Chowdhary (P)

Katharine Dormandy Haemophilia and Thrombosis Centre The Royal Free Hospital London UK.

Cedric Hermans (C)

Haemostasis and Thrombosis Unit Division of Haematology Cliniques Universitaires Saint-Luc Brussels Belgium.

Diane Nugent (D)

The Center for Inherited Blood Disorders (CIBD) Orange County California USA.

Nihal Bakeer (N)

Indiana Hemophilia & Thrombosis Center Indianapolis Indiana USA.

Sarah Mangles (S)

Haemophilia, Haemostasis & Thrombosis Centre Hampshire Hospitals NHS Foundation Trust Basingstoke UK.

Pamela Hilliard (P)

Child Health Evaluative Sciences, Research Institute The Hospital for Sick Children Toronto Ontario Canada.

Victor S Blanchette (VS)

Division of Hematology/Oncology The Hospital for Sick Children Toronto Ontario Canada.
Department of Pediatrics Faculty of Medicine University of Toronto Toronto Ontario Canada.

Brian M Feldman (BM)

Division of Rheumatology The Hospital for Sick Children Toronto Ontario Canada.
Department of Pediatrics Faculty of Medicine Institute of Health Policy, Management and Evaluation The Dalla Lana School of Public Health University of Toronto Toronto Ontario Canada.

Classifications MeSH